Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Jon Askaa | M | - |
Inbiomotion SL
 Inbiomotion SL Medical SpecialtiesHealth Technology Inbiomotion SL designs and develops diagnostic assays. It focus on genetic biomarkers, which predict the bone-specific metastases in cancer patients. The firm develops biomarker in breast cancer primary tumors for predicting the bone relapse. The company was founded by in 2010 and is headquartered in Barcelona, Spain. | - |
| David Lacey | M | 71 |
Inbiomotion SL
Inbiomotion SL Medical SpecialtiesHealth Technology Inbiomotion SL designs and develops diagnostic assays. It focus on genetic biomarkers, which predict the bone-specific metastases in cancer patients. The firm develops biomarker in breast cancer primary tumors for predicting the bone relapse. The company was founded by in 2010 and is headquartered in Barcelona, Spain. | 12 anni |
| Joël Jean-Mairet | M | 52 |
Inbiomotion SL
Inbiomotion SL Medical SpecialtiesHealth Technology Inbiomotion SL designs and develops diagnostic assays. It focus on genetic biomarkers, which predict the bone-specific metastases in cancer patients. The firm develops biomarker in breast cancer primary tumors for predicting the bone relapse. The company was founded by in 2010 and is headquartered in Barcelona, Spain. | - |
| José Antonio Mesa Cejudo | M | - |
Inbiomotion SL
Inbiomotion SL Medical SpecialtiesHealth Technology Inbiomotion SL designs and develops diagnostic assays. It focus on genetic biomarkers, which predict the bone-specific metastases in cancer patients. The firm develops biomarker in breast cancer primary tumors for predicting the bone relapse. The company was founded by in 2010 and is headquartered in Barcelona, Spain. | 4 anni |
| Juan Carlos Tercero Lopez | M | - |
Inbiomotion SL
Inbiomotion SL Medical SpecialtiesHealth Technology Inbiomotion SL designs and develops diagnostic assays. It focus on genetic biomarkers, which predict the bone-specific metastases in cancer patients. The firm develops biomarker in breast cancer primary tumors for predicting the bone relapse. The company was founded by in 2010 and is headquartered in Barcelona, Spain. | - |
| Giuseppe Viale | M | - |
Inbiomotion SL
Inbiomotion SL Medical SpecialtiesHealth Technology Inbiomotion SL designs and develops diagnostic assays. It focus on genetic biomarkers, which predict the bone-specific metastases in cancer patients. The firm develops biomarker in breast cancer primary tumors for predicting the bone relapse. The company was founded by in 2010 and is headquartered in Barcelona, Spain. | - |
| Andrew Tutt | M | - |
Inbiomotion SL
Inbiomotion SL Medical SpecialtiesHealth Technology Inbiomotion SL designs and develops diagnostic assays. It focus on genetic biomarkers, which predict the bone-specific metastases in cancer patients. The firm develops biomarker in breast cancer primary tumors for predicting the bone relapse. The company was founded by in 2010 and is headquartered in Barcelona, Spain. | - |
| Sebastián Chiavenna | M | - |
Inbiomotion SL
Inbiomotion SL Medical SpecialtiesHealth Technology Inbiomotion SL designs and develops diagnostic assays. It focus on genetic biomarkers, which predict the bone-specific metastases in cancer patients. The firm develops biomarker in breast cancer primary tumors for predicting the bone relapse. The company was founded by in 2010 and is headquartered in Barcelona, Spain. | 2 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Josep María Echarri Torres | M | 48 |
University of Barcelona
| 2 anni |
| Jordi Iserte | M | - |
University of Barcelona
| 5 anni |
| Julio Álvarez López | M | - |
University of Barcelona
| 3 anni |
| Pablo Cironi | M | - |
University of Barcelona
| 3 anni |
| Óscar Santos Juvé | M | - |
University of Barcelona
| 4 anni |
| Silvia Reina Pardo | F | 43 |
University of Barcelona
| 3 anni |
| Aleix Valls | M | - |
University of Barcelona
| 4 anni |
| Rima Yousfan Moreno | F | - |
University of Barcelona
| 4 anni |
| Josep Maria Tribó Capdevila | M | - |
University of Barcelona
| 4 anni |
| Miriam Bastida | M | - |
University of Barcelona
| 3 anni |
| Carl David Eric Malmström | M | 50 |
University of Barcelona
| 3 anni |
| Daniel Bach | M | - |
University of Barcelona
| 9 anni |
| Jordi Xaus | M | - |
University of Barcelona
| 1 anni |
| Juan F. Espinosa Parrilla | M | - |
University of Barcelona
| 3 anni |
| Marco Pugliese | M | - |
University of Barcelona
| 3 anni |
| Manuel José Rodríguez Allué | M | - |
University of Barcelona
| 3 anni |
| Elisabet Lázaro Mallén | M | - |
University of Barcelona
| 4 anni |
| Albertino Robelló Garcia | M | 42 |
University of Barcelona
| 4 anni |
| Caridad Pontes | M | - |
University of Barcelona
| 3 anni |
| Manel Barallat | M | - |
University of Barcelona
| 4 anni |
| Heidi Sisniega | F | - |
University of Barcelona
| 1 anni |
| Antonio Santidrian | M | 45 |
University of Barcelona
| 4 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Spagna | 30 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Roger Gomis Cabré
- Contatti personali
